Top entities: Health technology, Little Remedies, Arcadia Consumer Healthcare, Bacillus cereus, United States — Food and Drug Administration.

What category does this event fall under?

Regulatory — classified as product recall.

What is the sentiment of coverage?

Aggregate sentiment score: -20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Health technology issued voluntary recall · United States — Food and Drug Administration announced recall

Is this event still developing?

This event is archived — the story has concluded and this page is a final snapshot.

Regulatory product recall

Little Remedies Cough Syrup Recalled

Q: When did this event occur?

First reported Jun 18, 2025; last updated Jun 19, 2025.

Q: What is the market impact?

General. The recall of Little Remedies Honey Cough Syrup by Health technology, a subsidiary of Arcadia Consumer Healthcare, is likely to negatively impact Arcadia Consumer Healthcare's stock price due to concerns over product safety and potential financial liabilities.

Analysis based on 14 articles · First reported Jun 18, 2025 · Last updated Jun 19, 2025

Sentiment

-20

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The recall of Little Remedies Honey Cough Syrup by Health technology, a subsidiary of Arcadia Consumer Healthcare, is likely to negatively impact Arcadia Consumer Healthcare's stock price due to concerns over product safety and potential financial liabilities. The broader pharmaceutical and consumer goods industries may face increased scrutiny regarding quality control and product recalls.

Pharmaceuticals Consumer Goods

Event Summary

Health technology, a subsidiary of Arcadia Consumer Healthcare, has issued a voluntary nationwide recall of five lots of its Little Remedies Honey Cough Syrup. The recall, announced by the United States — Food and Drug Administration, is due to the presence of Bacillus cereus bacteria and a loss of shelf-stability in the product. The contaminated cough syrup was distributed between December 14, 2022, and June 4, 2025. While no serious adverse events have been reported, Bacillus cereus can cause foodborne illnesses characterized by nausea, vomiting, stomach cramps, and diarrhea, and in high levels, can be fatal. Consumers are advised to stop using the product immediately and contact a physician if symptoms occur. Health technology is offering reimbursements for the recalled items.

Key Actions

100 Health technology issued voluntary recall

80 United States — Food and Drug Administration announced recall

Entities Involved

oth

Health technology

Health technology initiated a voluntary recall of its Little Remedies Honey Cough Syrup due to bacterial contamination and loss of shelf-stability. This event negatively impacts the company's reputation and could lead to financial losses from refunds and potential lawsuits.

Importance 90.0 Sentiment -50.0

oth

Little Remedies

Little Remedies, as the brand affected by the recall, faces reputational damage and potential loss of consumer trust due to the contamination of its Honey Cough Syrup.

Importance 80.0 Sentiment -40.0

priv

Arcadia Consumer Healthcare

Arcadia Consumer Healthcare, as the parent company of Health technology, is indirectly affected by the recall of Little Remedies Honey Cough Syrup, potentially impacting its stock price and overall market perception.

Importance 75.0 Sentiment -30.0

oth

Bacillus cereus

Bacillus cereus is the bacteria identified as the contaminant in the recalled cough syrup, posing health risks to consumers.

Importance 60.0 Sentiment -100.0

govactor

United States — Food and Drug Administration

Importance 0.0 Sentiment 0.0

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard